一种高效筛选头颈癌患者接受自适应放疗的策略
本研究回顾性纳入110例接受现代光子放疗且至少每周5次治疗中重扫CT的头颈癌患者,利用半自动分割获取危及器官每周平均剂量并构建综合NTCP谱,以计划与实际Dmean差值及临床相关二分类差值BIOΔNTCP建模确定第1、2周最大ΔDmean截断值,比较四种ART候选筛选策略;结果显示第1、2周截断值联合使用的策略C在急性和晚期毒性方面均表现出最佳敏感度、特异度、阳性和阴性预测值。
要点
- maxΔDmean与BIOΔNTCP呈显著正相关(P<0.001)。
- 急性与晚期毒性主要BIOΔNTCP(>5%)的真候选患者分别占10.9%和4.5%。
- 策略C联合第1周截断值(3.01和5.14 Gy)与第2周截断值(3.41和5.30 Gy)表现最佳。
核心结论
- 作者提出一种高效的ART筛选策略,利用治疗前两周影像可将晚期毒性BIOΔNTCP>5%的患者亚组分类出来。
研究设计与样本
- 回顾性纳入110例接受现代光子放疗且至少每周5次治疗中重扫CT的头颈癌患者。
- 采用半自动分割方法获取危及器官每周平均剂量(Dmean),并应用综合NTCP谱获取NTCP值。
- 以计划与实际Dmean差值(ΔDmean)及临床相关二分类差值(BIOΔNTCP)建模,确定第1周和第2周危及器官最大ΔDmean截断值(maxΔDmean_1和maxΔDmean_2),并比较四种基于截断值maxΔDmean的ART候选筛选策略。
主要发现
- Spearman秩相关检验显示maxΔDmean与BIOΔNTCP呈显著正相关(P<0.001)。
- 对于急性毒性和晚期毒性主要BIOΔNTCP(>5%),真候选ART患者分别占10.9%和4.5%。
- 策略C联合使用截断值maxΔDmean_1(3.01和5.14 Gy)和截断值maxΔDmean_2(3.41和5.30 Gy)在急性毒性方面敏感度、特异度、阳性预测值和阴性预测值分别为0.92、0.82、0.38和0.99,在晚期毒性方面分别为1.00、0.92、0.38和1.00。
关键数值与推荐
- 急性毒性主要BIOΔNTCP>5%的真候选患者比例为10.9%。
- 晚期毒性主要BIOΔNTCP>5%的真候选患者比例为4.5%。
- 策略C的截断值maxΔDmean_1为3.01和5.14 Gy,截断值maxΔDmean_2为3.41和5.30 Gy。
- 策略C急性毒性敏感度0.92、特异度0.82、阳性预测值0.38、阴性预测值0.99。
- 策略C晚期毒性敏感度1.00、特异度0.92、阳性预测值0.38、阴性预测值1.00。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Adaptive radiotherapy (ART) is workload intensive but only benefits a subgroup of patients. We aimed to develop an efficient strategy to select candidates for ART in the first two weeks of head and neck cancer (HNC) radiotherapy. MATERIALS AND METHODS: This study retrospectively enrolled 110 HNC patients who underwent modern photon radiotherapy with at least 5 weekly in-treatment re-scan CTs. A semi auto-segmentation method was applied to obtain the weekly mean dose (Dmean) to OARs. A comprehensive NTCP-profile was applied to obtain NTCP's. The difference between planning and actual values of Dmean (ΔDmean) and dichotomized difference of clinical relevance (BIOΔNTCP) were used for modelling to determine the cut-off maximum ΔDmean of OARs in week 1 and 2 (maxΔDmean_1 and maxΔDmean_2). Four strategies to select candidates for ART, using cut-off maxΔDmean were compared. RESULTS: The Spearman's rank correlation test showed significant positive correlation between maxΔDmean and BIOΔNTCP (p-value <0.001). For major BIOΔNTCP (>5%) of acute and late toxicity, 10.9% and 4.5% of the patients were true candidates for ART. Strategy C using both cut-off maxΔDmean_1 (3.01 and 5.14 Gy) and cut-off maxΔDmean_2 (3.41 and 5.30 Gy) showed the best sensitivity, specificity, positive and negative predictive values (0.92, 0.82, 0.38, 0.99 for acute toxicity and 1.00, 0.92, 0.38, 1.00 for late toxicity, respectively). CONCLUSIONS: We propose an efficient selection strategy for ART that is able to classify the subgroup of patients with >5% BIOΔNTCP for late toxicity using imaging in the first two treatment weeks.
引用
- Gan Y, Langendijk JA, van der Schaaf A, et al. An efficient strategy to select head and neck cancer patients for adaptive radiotherapy. Radiother Oncol. 2023. PMID: 37353058. doi:10.1016/j.radonc.2023.109763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。